Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of the Imaging Working Group of the AEPC and the Cardiovascular Magnetic Resonance Section of the EACVI. by Valsangiacomo Buechel, E.R. et al.
POSITION PAPER
Indications for cardiovascularmagnetic resonance
in children with congenital and acquired heart
disease: an expert consensus paper of the Imaging
Working Group of the AEPC and the
Cardiovascular Magnetic Resonance Section
of the EACVI
E.R. Valsangiacomo Buechel1*, L. Grosse-Wortmann2, S. Fratz3, J. Eichhorn4,
S. Sarikouch5, G.F. Greil6,7, P. Beerbaum8, C. Bucciarelli-Ducci9, B. Bonello10,
L. Sieverding11, J. Schwitter12, and andW.A. Helbing13
Document reviewers: EACVI: Maurizio Galderisi (Italy), Owen Miller (UK), Rosa Sicari (Italy), John Simpson (UK),
Erik Thaulow (Norway), and Thor Edvardsen (Norway); AEPC: Konrad Brockmeier (Germany), Shakeel Qureshi
(UK), and Joerg Stein (Austria)
1Division of Paediatric Cardiology, Department of Paediatrics and Children’s Research Centre, University Children’s Hospital Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland;
2The Labatt Family Heart Centre, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada; 3Department of Paediatric Cardiology and
Congenital Heart Disease, Deutsches Herzzentrum Mu¨nchen, Klinikum an der Technischen Universita¨t Mu¨nchen, Munich, Germany; 4Department of Paediatric, Klinikum Leverkusen,
Leverkusen, Germany; 5Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany; 6Division of Imaging Sciences and
Biomedical Engineering, Rayne Institute, St Thomas’ Hospital, London, UK; 7Department of Congenital Heart Disease, Evelina Children’s Hospital, London, UK; 8Department of Paediatric
Cardiology and Paediatric Intensive Care Medicine, Children’s Hospital, Hannover Medical University, Hannover, Germany; 9Department of Cardiology, Bristol Heart Institute, NIHR
Bristol Cardiovascular Biomedical Research Unit, Bristol and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, NIHR Brompton Cardiovascular Biomedical Research
Unit, National Heart and Lung Institute, Imperial College, London, UK; 10Division of Cardiology, Timone Children’s Hospital, Aix-Marseille University, Marseille, France; 11Department of
Paediatric Cardiology, University Children’s Hospital, Tuebingen, Germany; 12Department of Internal Medicine, Division of Cardiology and Cardiac MR Center, University Hospital of
Lausanne, Lausanne, Switzerland; and 13Department of Paediatrics, Division of Paediatric Cardiology and Radiology, Erasmus University Medical Centre, Sophia Children’s Hospital,
Rotterdam, The Netherlands
Received 10 May 2014; accepted after revision 2 June 2014; online publish-ahead-of-print 17 February 2015
Thisarticleprovidesexpertopinionontheuseofcardiovascularmagnetic resonance(CMR) inyoungpatientswithcongenital heartdisease (CHD)and
in specific clinical situations. As peculiar challenges apply to imaging children, paediatric aspects are repeatedly discussed. The first section of the paper
addresses settings and techniques, including the basic sequences used in paediatric CMR, safety, and sedation. In the second section, the indication,
application, and clinical relevance of CMR in the most frequent CHD are discussed in detail. In the current era of multimodality imaging, the strengths
of CMR are compared with other imaging modalities. At the end of each chapter, a brief summary with expert consensus key points is provided. The
recommendations provided are strongly clinically oriented. The paper addresses not only imagers performing CMR, but also clinical cardiologists who
want to know which information can be obtained by CMR and how to integrate it in clinical decision-making.
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Introduction
As a result of spectacular improvements in diagnostics and treatment
options, survival of patients with congenital heart disease (CHD) has
increased dramatically. However, long-term morbidity and mortality
are substantial as is the need for reinterventions.1
Imaging features prominently in the pre- and postoperative man-
agement of patients with CHD. Diagnostic accuracy, burden to the
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patient, availability, and economics all have a role in the choice of the
appropriate imaging modality in clinical practice. Echocardiography
remains the mainstay of cardiovascular diagnostics, but other techni-
ques are gaining in importance, particularly cardiovascular magnetic
resonance (CMR) and computed tomography (CT; Table 1). Existing
expert opinion-based guidelines, focused on adult populations, for
the proper utilization of CMR are available.2 Specific challenges apply
to imaging children and adolescentswithCHD.These include the even
morepressingneed toavoid theuseof ionizingradiation, assessmentof
anatomy that is often complex and involves small structures, as well
as imaging at fast heart rates. The current paper aims to express the
consensus among experts in the field of paediatric CMR regarding its
use in young patients with CHD. It is beyond the scope of this paper
to discuss all technical details of CMR imaging in CHD, which have
been addressed elsewhere recently,3 much more to describe the use
of CMR in specific paediatric clinical situations.
Settings and techniques
In contrast to scanning adults with ischaemic heart disease, the CMR
approach to paediatric patients with CHD has to be individualized
and nearly all sequences need to be adapted to the patient’s size,
age, heart rate and, of course, the specific clinical question.4,5 There-
fore, it is of critical importance that CMR studies of young patients
with CHD are performed in centres with expertise in both the
haemodynamic situation at hand and the CMR technique used.4,5
The presence of an expert CMR reader throughout the length of
the study is typically required, as each heart is different and the sub-
sequent imaging steps need to be individually tailored upon on the
findings observed. High-quality results can be achieved only with a
commitment to invest time and resources for sometimes lengthy
scans and laborious post-processing of the data. Requirements
regarding dedicated training for performing congenital CMR have
been published.6 Requirements for institutional accreditation, and
particularly regarding a minimal case load, are available for adult
general CMR in Europe, but are still lacking for paediatric heart
disease and for CHD.7
Basic sequences used in paediatric CMR
The sequences utilized in routine paediatric CMR can be divided into
three main categories, following their purpose: to define morph-
ology, to assess function, including ventricular volumes and blood
flow, and to definemyocardial tissueproperties, including myocardial
perfusion as well as fibrosis. Recommendations for sequences to be
used for a given lesion are summarized in Table 2.
Anatomical imaging
In spin-echo imaging pulse sequences (often referred to as ‘dark-
blood’ or ‘black-blood’ sequences), flowing blood appears dark
whereas stationary tissues appear as varying shades of grey.8 The
main advantage of spin-echo sequences is that they are less suscep-
tible to artefacts caused by turbulent flow and metallic implants.9
Respiratory motion is usually addressed by breath-holding, multiple
averages, or diaphragm tracking.
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Table 1 Comparison of available imaging modalities for assessment of different conditions
Echo CMR CT Catheterization
Aortic arch ++ +++ +++ +++
Pulmonary arteries ++ +++ +++ +++
Pulmonary veins ++ +++
Precise anatomical information
+ flow measurements
++ +++
Wedge pressure
AV valves +++ + (+) +
Pressure gradients
Semilunar valves +++ ++
Quantification of regurgitation
+ +
Pressure gradients
Complex CHD ++ +++
Precise anatomical information
+ flow measurements
++ ++
Pulmonary arterial pressure
Coronary arteries +
Only proximal
segments
++ +++ +++
Gold standard
Tissue characterization
(tumours and cardiomyopathies)
+ +++ + (+)
Ventricular function ++ +++ (+)
ECG-gated CT
++
Flow measurements + +++ – –
Shunt quantification + +++ – +++
(+): limited application, major limitations;+: can be used in the assessment of this lesion, but has some significant limitations and better alternatives areavailable;++: useful technique
commonly applied in the assessment of the lesion, and it may present some limitation;+++: technique of choice for the assessment of the lesion; – : cannot be adequately assessed
with this modality.
E.R. Valsangiacomo Buechel et al.282
In steady-state free precession (SSFP) acquisitions, blood appears
bright. Images can be displayed as a cine loop.8 Two-dimensional
(2D) SSFP is the most frequently used sequence for anatomical
imaging in CHD, as it allows views in any desired plane and adds quali-
tative information about function and valve motion. Image acquisition
is usually performed during breath-holding. However, images can
also be acquired during free-breathing in most paediatric patients.
Cardiac motion is usually controlled by means of retrospective
gating to ECG as this allows including the end-diastolic heart phase,
as opposed to prospective ECG-triggering.
Contrast-enhanced magnetic resonance angiography (CE-MRA) uses
intravenously administered gadolinium-based contrast agents to
reduce T1 relaxation time of blood and improve the contrast
between the blood pool and the surrounding tissue.10,11 The
increased contrast (signal) allows adjusting the acquisition para-
meters for obtaining high-resolution images.12,13 The dataset—a
full volume composed of a stack of contiguous slices—can be recon-
structed in any desired oblique plane (multiplanar reformats and
maximum intensity projection images) or volume-rendered in a
three-dimensional (3D) image. For optimal quality of the CE-MRA
images, the sequence and particularly the timing of image acquisition
need to be designed for the clinical question and the vessels that need
to be assessed. Even in small children, high spatial resolution with sub-
millimetre resolution can be achieved with CE-MRA in which the
images are acquired during breath-holding.14,15 Using this technique,
even subtle variations in luminal diameters can be detected. Thus,
CE-MRA has become widely accepted in the diagnosis of vascular
disease in children, and cardiac catheterization can frequently be
avoided.13,16,17
CE-MRA is acquired without ECG-triggering and the recon-
structed images represent an average appearance over the cardiac
cycle. For this reason the edges of pulsatile vascular structures,
such as the aortic root, as well as the coronaries appear blurry.
In time-resolved MR angiography techniques, the dynamic distribu-
tion of contrast medium into the pulmonary vasculature can be
observed. Without dedicated timing of image acquisition, artefacts
from motion are minimized and separation of arteries and veins is
possible.18
3D SSFP is an ECG-triggered pulse sequence with respiratory
motion compensation by diaphragmatic navigators19 –21 or naviga-
tion on the heart itself, called self-navigation.19 These sequences
can be combined with contrast media or not and produce a
high-resolution 3D dataset of the whole heart and intrathoracic
vasculature.20 – 22 Owing to the double gating (ECG and respira-
tory), cardiovascular structures close to the heart, such as the
aortic bulb and the proximal coronary arteries, can be delineated
very clearly.19,23,24 Image reconstruction is usually performed using
multiplanar reformatting.
Functional imaging
Ventricular volumes and ejection fraction are assessed by acquisition of a
stack of SSFP cine slices (as described above) covering the entire
heart.8 The stack can be aligned in a ventricular short-axis plane par-
allel to the atrioventricular valves or perpendicular to the ventricular
septum or in an axial plane transverse to the thorax.25– 28 Measure-
ments should be performed consistently using the same orientation,
as results from short axis and axial orientations are not interchange-
able. On the stack of cine slices, end-diastolic and -systolic volumes
and mass of both ventricles are derived by contouring the endocar-
dial and epicardial borders. This method is based on Simpson’s sum-
mation of discs method with minimal geometrical assumption. This is
of particular importance in the right ventricle or in functionally single
ventricles. Normal values forboth ventricles andboth atria havebeen
published in children,25– 27,29 andhigh reproducibilityof the measure-
ments has been demonstrated in children with CHD and with normal
hearts.25,30 A consensus policy regarding ventricular segmentation,
i.e. inclusion or exclusion of papillary muscles and trabeculations,
leads to an even better reproducibility of the measurements.31
Blood flow across a vessel can be measured accurately by using a
velocity-encoded phase-contrast (PC) cine sequence. Typically, a slice is
placed perpendicular to the vessel of interest. After contouring the
vessel of interest, the volume of blood passing through the plane is
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Table 2 Summary of the sequences recommended for imaging different conditions
Lesion BB SE 2D SSFP CMR sequence Perfusion imaging LGE
PC flow 3D CEMRA 3D SSFP
Aortic arch anomaly + ++ ++ +++ ++a
Pulmonary arteries + + ++ +++ ++a
Pulmonary veins + + + +++ ++a
Shunt lesions ++ ++ +++ ++
TOF ++ +++ +++ ++ ++a ++
Complex CHD ++ +++ +++ ++ +++
Single ventricles ++ +++ +++ ++ ++a ++
Intracardiac tumours ++ ++ +++ ++
Cardiomyopathies + ++ ++ ++ +++
Coronary arteries ++ +++ ++
+: may be used in the assessment of this lesion, but better alternatives available or does not provide additional information over other techniques; ++: useful technique, commonly
applied in the assessment of the lesion; +++: needs to be part of any study in this lesion.
aIf contrast needs to be avoided. BB SE, Black blood spin-echo.
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calculated as the product of velocity and cross-sectional area.32
In general, when assessing CHD, it is advisable to perform measure-
ments in all large arteries, i.e. aorta, pulmonary trunk, and side
branches, as well as in the caval veins and to compare the results
for internal consistency.
First-pass myocardial perfusion imaging uses the dynamic inflow of
gadolinium-based contrast medium into the myocardium to depict
zonesofdecreasedperfusion.Areasof reducedmyocardial perfusion
will remain dark, whereas normal perfusion shows a bright myocar-
dial signal with the advent of gadolinium. The test can be performed
at rest or under pharmacological stress for more clear depiction of
ischaemia.8,33,34 The option to perform perfusion imaging at rest
and during stress in combination with superior spatial resolution
compared with single photon emission computed tomography
(SPECT) makes it an attractive technique.35
Stress imaging assesses ventricular function by 2D SSFP under
pharmacological stress with dobutamin or exercise stress with
CMR-compatible equipment. Stress imaging is performed in some
centres in selected borderline clinical situations to test contractile
reserve of a systemic chamber, such as in a right ventricle in systemic
position or in univentricular hearts.36
Late gadolinium enhancement (LGE), or myocardial delayed
enhancement, is a technique demonstrating abnormal deposition of
contrast agent within the myocardium late after contrast medium
injection.The focal hyperenhancedareas represent regions ofmyocar-
dial fibrosis.8 Fibrotic and necrotic areas in the myocardium appear
bright on LGE images in contrast to the dark healthy myocardium. In
children with CHD, LGE may result from scars after infarction, surgical
scars in the myocardium, and/or from surgically placed patches.37
In younger children, obtaining adequate temporal and spatial reso-
lutions may represent a technical challenge, as the structures of inter-
est are smaller and heart rates higher than in adults.14
Expert consensus key points
(i) Black-blood spin-echo, 2D SSFP, and3DSSFP techniques aswell
as contrast-enhanced MR angiography are the most important
sequences for anatomical imaging in CHD.
(ii) In children, higher spatial and temporal resolution is required to
account for higher heart rates and smaller anatomical structures
than in adults.
(iii) CMR is the current clinical gold standard for measurements of
ventricular function and blood flow. Both are crucial compo-
nents of a CMR examination in patients with CHD.
Sedation and anaesthesia
In younger children, typically before school-age, a CMR examination
usually requires sedation or general anaesthesia. In young patients
with complex CHD, in spite of the burden of general anaesthesia,
CMR can be utilized for completing diagnosis before surgical repair
or for planning other therapeutic interventions,5,14 and purely diag-
nostic cardiac catheter examination with its related potential compli-
cations can usually be avoided.38– 40
The preferences and availability of sedation and/or general anaes-
thesia differ from centre to centre, and advantages and risks of each
technique are discussed elsewhere.41,42 When sedation or general
anaesthesia is used, appropriate monitoring of the patient and
presence of an expert team which is versed in the administration of
drugs and equipped to deal with emergencies is mandatory.
Even though patients under anaesthesia, infants younger than 1
year, inpatients, and ICU patients are at higher risk for adverse
events during CMR than the general outpatient population,43 it has
been shown that CMR can be safely performed even in critically ill
infants, if carried out by a dedicated team.44 Careful analysis of the
risks and benefits of a CMR examination under general anaesthesia
needs to be performed before the procedure.
Certain patient groups, including those younger than 3 months of
age, patients with a functional single-ventricle physiology, pulmonary
hypertension, unrepaired cyanotic CHD, or airway pathology, may
require hospitalization.45
Expert consensus key points
(i) Dedicated staff and MR compatible equipment are necessary for
performing general anaesthesia or deep sedation in children with
CHD undergoing CMR.
(ii) In patients requiring anaesthesia or sedation, the risks and bene-
fits of the procedure should be balanced carefully.
Safety and contraindications
Except for patients requiring general anaesthesia, the safety issues for
CMR in children with CHD do not differ from those in general paediat-
ric magnetic resonance imaging, and CMR is a safe imaging procedure.
The main advantages of CMR are the lack of ionizing radiation and its
non-invasiveness. Particularly, the use of radiation-free modalities is
very important in children, as their risk fordeveloping radiation-induced
cancer is three to four times higher than in adults.46 Correspondingly,
CMR has a favourable benefit/risk profile compared with cardiac cath-
eterization and CT.47
The most important step to reduce potential risks of CMR scan-
ning is to establish a strict policy of screening before CMR for the
patient and all accompanying persons, including parents and
medical personnel.48 This is particularly important to avoid the
so-called missile effect caused by ferromagnetic objects drawn
rapidly into the scanner by massive magnetic forces.49
Other potential safety issues related to CMR relate to hyperther-
mia, acoustic noise, implantable devices, and nephrogenic systemic
fibrosis (NSF).
If used according to the manufacturer’s recommendations, CMR at
1.5 or 3 T does not pose any safety concerns with regard to energy
deposition and hyperthermia.50 Nevertheless, it is important to
note that thermoregulatory mechanisms are immature in infants,
abnormal in patients with cardiovascular disease, and can be influ-
enced by some medications such as diuretics, calcium blockers,
beta-blockers, amphetamines, and sedatives. Acoustic noise during
CMR scanning can cause temporary or permanent hearing impair-
ment. Adequate precautions to shield patients, including infants,
should be taken at all times.
In general, most cardiovascular devices implanted nowadays are
MR compatible and safe to be scanned. www.mrisafety.com provides
specific safety information for specific devices and should be con-
sulted before scanning.51 Cochlear implants and cerebrospinal fluid
shunts are non-cardiovascular implants that may be present in
CHD patients. CMR is contraindicated in patients who have a
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cochlear implant. Most cerebrospinal shunts are CMR compatible,
but manufacturer-specific safety guidelines must be followed.
Cardiac pacemakers and implantable cardioverters/defibrillators
(ICDs) are generally considered a relative contraindication to enter-
ing the MR environment.52 CMR-compatible cardiac pacemakers
havebeen recentlydeveloped andarecurrentlyundergoing testing.53
Severe complications of gadolinium-derived contrast agents are
rare in paediatric patients. Common side effects include extravasation
of the contrast agent and allergic reactions from mild skin rash to car-
diovascular decompensation. NSF is a rare but serious condition that
consists offibrosis of skin, joints, eyes, and internalorgans.54 Thedevel-
opment of NSF has been linked to the biochemical structure of
gadolinium-containing contrast agents in the presence of end-stage
renal failure. Thus, all patients who are candidates for gadolinium-
derived contrast medium administration must be screened for renal
dysfunction, and in infants ionic macrocyclic contrast agents should
be used.55,56
Expert consensus key points
(i) CMR in children and adolescents with heart disease has a high
safety profile.
(ii) Lack of radiation is the most striking advantage over other
advanced imaging modalities.
(iii) Main contraindications for CMR in childhood are cochlear
implants, old-generation pacemakers, ICDs, and other non-
compatible implants.
(iv) The use of gadolinium-derived contrast agents is contraindi-
cated in children with end-stage renal failure, due to the risk
for developing NSF.
Clinical applications
Aortic arch anomalies
Common indications for performing CMR in anomalies of the aortic
arch include vascular rings (Figure 1), interrupted aortic arch, truncus
arteriosus communis, complex forms of aortic coarctation, and con-
genital connective tissue disorders, such as Marfan and Turner syn-
drome.57,58 CMR can be performed at the time of diagnosis in
order to refine an echocardiographic diagnosis and during follow-up
after surgical correction or catheter intervention, when residual or
recurrent stenoses and/or aneurysms need to be ruled out.58– 60
Stents in the aortic arch are not a contraindication for CMR;
however, CMR is not suited to evaluate stent patency.The sequences
used for imaging the aortic arch are summarized in Table 2.
The sensitivityof CMRtechniques todetect vascular abnormalities
is as good as that of conventional catheter angiocardiography
(Table 1), so that cardiac catheterization can be reserved for selected
cases and for catheter-guided interventions.61
The ability to generate 3D anatomical images by CEMRA or 3D
SSFP allows decision-making on the most appropriate treatment
technique, i.e. cardiac surgery or catheter-guided intervention.61–64
CT angiography is a sound alternative particularly when associated
airway anomalies are suspected and/or when the clinical scenario is
that of a young and sick infant or neonate.
In coarctation of the aorta, haemodynamic assessment is performed
with a velocity-encoded PC cine sequence using high velocity
encoding typically of at least 200 cm/s.65 Flow measurements are
usually performed in a perpendicular plane through the ascending
aorta, proximal descending aorta (aortic isthmus, immediately distal
to the stenosis), and at the level of the diaphragm. An increase in flow
between the distal aortic arch and the descending aorta at the level of
the diaphragm is indicative for significant collateral circulation. In add-
ition, the velocity of the jet at the level of the stenotic isthmus, if PC
measurement is performed accordingly, provides semi-quantitative
information about the severity of vascular narrowing.
Expert consensus key points
(i) CMR is the first-line advanced imaging technique beyond echo-
cardiography for the anatomical assessment of aortic arch
anomalies.
(ii) Reconstructed 3D CMR images are helpful for planning inter-
ventions of the aortic arch.
(iii) CMR has an important role in follow-up after an intervention.
(iv) Blood flow measurements add functional information to the
anatomical images.
The pulmonary arteries
The advantages of CMR imaging compared with other modalities are
very good anatomical visualization of right ventricular outflow tract
(RVOT), pulmonary bifurcation, and pulmonary side branches,
combined with functional information. CMR is the only technique
allowing quantitative flow measurements in the pulmonary arteries
(Table 1).66
Anatomical imaging of the pulmonary arteries can be done by var-
ious angiographic techniques, as described above and in Table 2.57,67
CE-MRA has been validated against conventional angiography13 and
has also been demonstrated to reliably detect aorto-pulmonary col-
lateral arteries in tetralogy of Fallot (TOF) with severe pulmonary
stenosis or atresia.16 Furthermore, CMR provides clear visualization
of the spatial alignment of the pulmonary bifurcation, as well as of the
relationship between the pulmonary arteries and the surrounding
Figure 1: Double aortic arch as shown in a 3D reconstruction
from a contrast-enhanced MR angiography. View from the front
(A) and from cranial (B).
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structures, such as the airways and other vascular structures such as
the aorta (Figure 2).67
Flow measurements by velocity-encoded PC cine add functional
information to anatomical findings and are crucial for assessing the
need for interventions (Figure 2). Flow redistribution in the pulmon-
ary arteries has been observed not only in the presence of pulmonary
artery stenosis, but also in pulmonary venous obstruction.68 –70
Beside quantitative flow assessment, qualitative flow profiles may
provide information about anomalous pulmonary resistance.
The presence of a stent in a pulmonary artery does not represent a
contraindication for performing CMR imaging during follow-up
assessment. Flow measurement can still be performed accurately, if
PC cine images are acquired at a reasonable distance from the
stent. Alternatively, pulmonary venous flow can be used as a surro-
gate for ipsilateral pulmonary arterial flow (Table 3).
Expert consensus key points
(i) CMR combines a detailed visualization of the spatial alignment of
the pulmonary arterial bifurcation and the side branches.
(ii) Through-plane flow measurements can accurately quantify dif-
ferential lung perfusion in various conditions.
The pulmonary veins
CMR is considered the gold standard for assessing anomalous con-
nection and stenosis of the pulmonary veins. CMR combines
superb luminal anatomy, accurate quantification of blood flow pat-
terns and volume and, importantly, information about the surround-
ing structures (Table 1).71,72
To obtain anatomical information about the vessel lumen in both
pulmonary vein stenosis and anomalous connection, CE-MRA and/or
3D SSFP can be used (Figure 3). Alternatively to, or in conjunction
with angiography, SSFP cine imaging along the vessel’s long axis can
provide useful information, particularly if dynamic external compres-
sion is suspected.
Velocity-encodedPCcine is apowerful tool in the characterization
of pulmonary venous pathology. It is used to measure right and left
pulmonary arterial blood flow, to detect signs of pulmonary hyper-
tension, and to unveil redistribution of blood flow away from affected
areas of the lung.70
In anomalous pulmonary venous connection, it is important to
detail the course and connection of each pulmonary vein, diagnose
or rule out the presence of pulmonary venous obstruction, quantify
the degree of left-to-right shunting (Qp/Qs), and describe associated
lesions.69,73
A number of indicators during a CMR examination signal the pres-
ence of pulmonary vein stenosis.71,74,75 The most obvious sign of
obstruction is morphologically narrowing of the pulmonary venous
lumen. This is best imaged by targeted SSFP cine imaging and
CE-MRA. In some instances, veno-venous collaterals to unobstructed
pulmonary venous channels and/or to systemic veins are present.
Furthermore, higher than normal flow velocity distal to a suspected
narrowing and loss of the normal phasic velocity flow profile are sug-
gestive of a haemodynamically significant obstruction.75 Finally, as
mentioned above, long-standing pulmonary venous narrowing
leads to redistribution of pulmonary blood flow away from lung seg-
ments drained by the stenosed pulmonary vein, and results in an
unbalanced lung perfusion, as easily detectable by velocity-encoded
PC measurements in the branch pulmonary arteries.
Expert consensus key points
(i) CMR is considered the gold standard for assessing anomalous
connection and stenosis of the pulmonary veins.
(ii) Combined blood flow measurements in the pulmonary veins and
in the pulmonary arteries allow understanding the complex flow
redistribution occurring in the presence of pulmonary venous
obstruction and aorto-pulmonary collateral flow.
Figure2: In apatientwith transposition of the great arteries, who
underwent the arterial switch operation with Lecomte manoeuvre,
contrast-enhanced MR angiography demonstrates well the rela-
tionship between the pulmonary arteries and the surrounding
structures, in this case the ascending aorta (A). Flow measurements
in the right pulmonaryartery (B) and in the left pulmonary artery (C)
show a balanced lung perfusion with 50%/50% flow to the right and
to the left. AO, aorta; MPA, main pulmonary artery; LPA, left pul-
monary artery; RPA, right pulmonary artery.
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Shunt lesions
The exact quantification of intracardiac shunts is part of the compre-
hensive haemodynamic evaluation in many patients with CHD and
often a determinant factor for surgery. CMR is an established modality
for the non-invasive assessment of shunt location, flow direction, and
magnitude.76 Anatomical detectionof lesions resulting in shunt flows is
typically performed with cine acquisitions. When obtained perpen-
dicular or parallel to the intracardiac shunt direction, they provide a
valuable assessment of the defect location and size of intracardiac
shunt lesions throughout the cardiac cycle. Extracardiac shunts, such
as major aorto-pulmonary collaterals and anomalous pulmonary
venous connection, are readily delineated by CE-MRA.71,77
Shunt calculation is one of the major strengths of CMR. As it pro-
vides accurate flow measurement in every desired vessel, CMR can
overcome the well-known limitations of the traditional Fick’s
method by oximetry as obtained with invasive techniques, or of
Doppler echocardiography, which cannot quantify flow reliably.32,78
By using the velocity-encoded PC cine sequence, the ratio of pul-
monary blood flow (Qp) and systemic blood flow (Qs) can be accur-
ately quantified and reflects the size of shunt.
Independently of the location of the shunt, Qp is always the sum of
pulmonary venous flow and Qs is always the sum of inferior and su-
perior venae cavae flows, measured close to the heart.79 Flow in the
descending aorta may be used as a substitute for inferior vena cava
flow and is technically easier to obtain. Depending on the anatomy,
i.e. the location of the shunt, flows other than the pulmonary veins
and the caval veins can be used as Qp and Qs, respectively (Table 3).
Another method to assess the magnitude of net shunts is to
compare the selective cardiac output of the right with that of the
left ventricle (Table 3). This method is commonly thought to be
less accurate than velocity-encoded PC by many, owing to difficulties
in accurately contouring the right ventricular (RV) endocardium in-
cluding its trabeculations. Furthermore, this approach is inherently
invalid in the presence of valvular regurgitation. For the purposes
of ‘internal validation’, that is, to assess the accuracy of the flow mea-
surements, Qp and Qs measured by different methods should be
compared.
Expert consensus key points
(i) CMR can be used for the anatomical detection of intracardiac
and extracardiac shunts.
(ii) Shunt calculation is one of the major strengths of CMR.
(iii) Comparison of shunt quantifications using various measure-
ments is recommended for ‘internal validation’ of the data and
to increase accuracy.
Tetralogy of Fallot
TOF has become one of the main indications for performing CMR
during follow-up of CHD after surgical repair.2 In youngchildren, pre-
operatively, advanced imaging with CMR is only required in few
selected cases with associated lesions such as situs anomalies,
aortic arch anomalies, disconnected branch pulmonary arteries,
and/or aorto-pulmonary collaterals. After initial surgical repair,
typical residual findings during mid- and long-term follow-up
include moderate to severe incompetence of the pulmonary valve,
obstruction of the RV outflow tract, and/or branch pulmonary
arteries. These findings cause chronic volume and/or pressure load
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Table 3 Flowmeasurements for the assessment of
pulmonary (Qp) and systemic blood flows (Qs) in extra-
und intracardiac shunt lesions
Qp Qs
Intracardiac
shunt
PVs SVC + IVC
RPA + LPA SVC + DAO
MPA AAO
Stroke volume RV
(ASD and PAPVC)
Stroke volume LV
(ASD and PAPVC)
Extracardiac
shunt
PVs SVC + IVC
RPA + LPA
(AP window)
SVC + DAO
AAO
Stroke volume LV
(PDA, AP window
and AP collaterals)
Stroke volume RV
(PDA, AP window
and AP collaterals)
AAO, ascending aorta; AP, aorto-pulmonary window or collaterals; DAO,
descending aorta; IVC, inferior vena cava; LPA, left pulmonary artery; LV, left
ventricle; MPA, main pulmonary artery; PDA, patent ductus arteriosus; PVs,
pulmonary veins; RPA, right pulmonary artery; RV, right ventricle; SVC, superior
vena cava.
Figure 3: Maximum intensity projection reconstruction of
CE-MRA images in the coronal plane in a patient with Scimitar syn-
drome. All right-sided pulmonary veins drain via a common channel
to a stenotic connection with the inferior vena cava (not opacified).
The pulmonary venous blood from the right lung drains via collat-
erals to the dilated hepatic veins. The left-sided pulmonary veins
drain normally to the left atrium (left upper pulmonary vein not
shown).
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of the right ventricle, with well-described and potentially lethal
complications.80
Over the past two decades, CMRhas been firmlyestablished as the
key imaging modality for serial follow-up in TOF patients.2 CMR is the
only technique that allows accurate quantification of pulmonary in-
competence with measurement of regurgitation volumes and regur-
gitation fraction (both should be documented) by PC cine imaging
(Table 1).81,82
The volume and systolic function of both ventricles are deter-
mined by acquiring a stacked 2D-cine SSFP covering the ventricles
in short-axis or axial orientation25,28 (Figure 4). This method has ex-
cellent reproducibility if performed in a standardized manner across
institutions.31,83 Tricuspid valve regurgitation can be depicted using
2D SSFP, but is difficult to be correctly quantified due to the move-
ments of the annulus plane during the cardiac cycle and to the
usually co-existing pulmonary incompetence. Tailored 2D SSFP
images through the RVOT, 3D SSFP, and/or CE-MRA give clear
views of the anatomy of the RVOT and the pulmonary side branches.
Additional functional information can be obtained by measuring the
differential pulmonary perfusion and assessing the backflow separ-
ately in both pulmonary side branches.84,85
All this information is generally used in the clinical management of
these patients and consideredof particular importance in timing deci-
sions regarding pulmonary valve replacement.
In this context, RV size and function are the main factors to be con-
sidered in addition to clinical symptoms and findings. Although there
is no universal agreement on cut-off volume, an indexedend-diastolic
RV volume of 160 ml/m2 and an end-systolic RV volume of 80 ml/m2
have been shown to predict normalization of RV size after pulmonary
valve replacement.86 Proper selection of patients undergoing percu-
taneous pulmonary valve implantation requires accurate description
of the geometry of the RVOT by CE-MRA or 3D SFFP and exclusion
of anomalies of the coronary arteries by 3D SSFP.
The presence of myocardial scarring is detected by LGE of the
myocardium, the extent of which has been found to be related to ex-
ercise intolerance, regional wall motion abnormalities, and propen-
sity for arrhythmia.
Targeted 2D SSFPor CE-MRA mayadditionally detect dilatation of
the ascending aorta, demonstrate arch sidedness (right aortic arch in
20% of patients with TOF), and exclude potential major aorto-
pulmonary collateral arteries.87
Expert consensus key points
(i) CMR is the key imaging modality for serial follow-up in TOF
patients.
(ii) CMR enables the assessment of RV outflow tract, pulmonary
bifurcation, and pulmonary arteries as well as quantification
of RV volume and function and regurgitant blood flow in
pulmonary regurgitation.
(iii) This information features prominently in surgical decision-
making around pulmonary valve replacement.
Complex CHD
ComplexCHDfrequentlyconsistsof acombinationof situsanomalies,
abnormal atrioventricular and/or ventriculo-arterial connections, and/
or additional defects, including septal defects, ventricular looping
anomalies, as well as malformations of the outflow tracts. In addition,
malformations of the extracardiac thoracic vessels and tracheo-
bronchial anomalies may be present.
Planning and performing CMR examinations in patients with
complex CHD require thorough expertise in congenital malforma-
tions to avoid misinterpretation or incomplete results.
Dedicated CMR examinations provide a comprehensive picture of
complex CHD, including anatomy and haemodynamics (Table 1).
Three-dimensional reformatting algorithms may enhance surgical
decision-making and planning of operative procedures.46
In complex CHD, views in axial, coronal, and sagittal orientations
should always be at the beginning of every CMR exams to facilitate
orientation within the thorax. Oblique imaging planes are tailored
towards individual aspects of anatomy and for ventricular function
and flow analyses. The abdomen should be covered in the
localizer/scout images and by techniques, enabling the identification
of vessel anatomy and size as well as anatomy of the upper abdominal
organs88 (Figure 5).
Turbo spin-echo sequences are particularly useful for the evalu-
ation of tracheo-bronchial anomalies and their relationship to the
pulmonary vascular tree which provides important clues to the
thoracic situs and for the detection of anomalies of the great
arteries.
The use of CMR in complex CHD including heterotaxy syndrome
has been validated in numerous studies89 and has been demonstrated
to provide superior delineation of the abdominal situs, of pulmonary
and systemic venous malformations, and of the relationship of the
heart to abdominal and mediastinal structures compared with echo-
cardiography and cardiac catheterization.88,90–92 Thus, CMR has
been recently recognized as the first-line imaging modality for
imaging complex CHD.2
Expert consensus key points
(i) CMR is an important adjunct to echocardiography for imaging
complex CHD in children and in adults.
(ii) CMR provides complete information about situs, segmental
cardiac connections, additional intracardiac and extracardiac
malformations, and accurate haemodynamic information.
Single ventricles throughout staged
palliation
The palliative treatment strategy for functionally univentricular
hearts may require between two and three or more procedures
before achieving the stage of the Fontan-type circulation.93,94
Strengths of CMR in the setting of single-ventricle circulations
include the detailed assessment of potentially complex anatomy, par-
ticularly of the large vessels, functional imaging of the ventricles and
large vessels throughout the stages, and assessment of flow, particu-
larly of the pulmonary/Fontan circulation (Figure 6).
Prior to the creation of a partial cavopulmonary connection,
imaging of the ascending aorta and aortic arch, of the pulmonary
arteries, and of the systemic and pulmonary veins are mandatory.95
Ventricular size and function, valve function, and the subaortic
outflow tract should be studied. A combination of 2D and 3D
SSFP, black-blood, phase-contrast sequences and/or CE-MRA can
be used for these purposes (Table 2).96 A combined protocol using
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Figure 4: 2D SSFP of the ventricles in a patient with dilated RV after TOF repair as demonstrated in an axial stack (A) and in a short-axis stack (B).
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echocardiography and CMR may result in less complications when
compared with cardiac catheterizations and similar long-term out-
comes in properly selected patients.97 Imaging of an aorto- or
ventriculo-pulmonary shunt can also be achieved with CMR by
using 3D SSFP or CE-MRA.14
Before completion of a total cavopulmonary connection (TCPC),
a similarly detailed work-up is required. In addition, the connection
between the superior vena cava and the pulmonary arteries has to
be visualized. The presence of significant aorto-pulmonary collateral
vessels can be demonstrated by using CE-MRA. The difference of
total pulmonary venous flow and the total branch pulmonary arterial
flow allows quantifying the additional blood flow to the lungs due to
aorto-pulmonary collaterals.98 The use of only CMR for planning the
TCPC stage is being discussed;19 however in most centres, haemo-
dynamic studies before the completion of a Fontan-type circulation
are still performed including cardiac catheterization (Table 1).
After completion of the Fontan circulation, CMR is recommended
for serial follow-up of systolic and diastolic ventricular function, ven-
tricular geometry, and serial quantification of valvular incompe-
tence.94,95,99 Stress imaging can be used for testing ventricular
contractile reserve in selected cases.36 Additional useful information
provided by CMR during follow-up includes anatomy and function of
the Fontan pathway, identifying obstructions, baffle leaks, thrombus
formation, and collateral flow.
Expert consensus key points
(i) In patients with single ventricles, CMR is recommended after
Fontan completion for serial follow-up of ventricular function
and anatomical assessment of the Fontan pathway.
(ii) During stagedpalliation, CMRcan be used to detect residual find-
ings requiring additional interstage interventions.
Cardiac tumours
Paediatric cardiac tumours are rare and usually benign (75–90%).
Rhabdomyomas and fibromas are the most frequent cardiac
tumours in children. Among malignant tumours, metastatic involve-
ment from non-Hodgkin lymphoma, leukaemia, neuroblastoma,
nephroblastoma, or sarcoma is much more common than primary
cardiac sarcoma or lymphoma.100
CMR fulfils all the diagnostic goals of tumour imaging in one single
examination (Table 1).101,102 Thus, a CMR examination should describe
size and location of the tumour; evaluate any haemodynamic relevance,
such as obstructions to inflow oroutflowand impairment of myocardial
and/or valvular function; describe the specific tissue properties of the
mass, including signal /intensity ratio, infiltration of adjacent tissue,
tissue appearance. Exact location in relation to the cardiac structures
(endoluminal, floating, intramyocardial) should be included (Figure 7).
For a comprehensive evaluation of an intracardiac mass, the fol-
lowing imaging sequences and orientations are recommended: cine
Figure5: Four-year-old boy with right atrial isomerism, bilateral superior caval veins, univentricular atrioventricular connection to a solitary ven-
tricle, pulmonary atresia, and right aortic arch developed severe hypoxaemia after Fontan completion due to a non-included left-sided hepatic vein.
(A) Multiple intrahepatic collateral channels underscoring a right-to-left shunt from the right hepatic vein (RHV; asterisk) to the left hepatic vein
(LHV) and to the left-sided atrium. Contrast agent is applied via the left lower limb. (B) T2-weighted SSFP transverse plane 3 cm below the dia-
phragm. Visceral heterotaxia. Both descending aorta (Ao) and inferior caval vein (IVC) are right-sided. RHV and LHV are arranged in nearly parallel
fashion midline. (C) Flow measurement using velocity-encoded PC for quantification. Flow direction is encoded by optical density. Dark lumens
indicate flow directed caudally. Reversely, bright lumens indicate flow directed cranially.
E.R. Valsangiacomo Buechel et al.290
SSFP in an axial and oblique imaging plane across the tumour,
T1-weighted TSE with and without fat suppression covering the
tumour as well as the uninvolved ventricular myocardium,
T2-weighted TSE, first-pass perfusion and LGE
103 (Table 2). First-
pass myocardial perfusion imaging may provide useful information
about tumour vascularity. Moderate and strong enhancement is
more indicative of malignant processes, whereas mild enhancement
is found in up to 40–50% of benign tumours as well as in highly vas-
cularized tumours.101,103 LGE does not predict malignancy, but is
very helpful in tissue characterization. When an intracardiac throm-
bus is suspected, LGE imaging with a long inversion time (600 ms) is
recommended (Figure 8).104
After having acquired all the different images, a correct diagnosis of
the type of tumour can be derived by using the criteria proposed from
a recent multicentre paediatric data collection.103 These criteria based
on tissue characteristics shown by the different sequences used
achieved a diagnostic accuracy of up to 97%, with a single correct diag-
nosis in 55% and acorrect differential diagnosis in 42%, respectively.103
Diagnosis of malignancy can be at least suspected on the basis of
tumour location, tissue inhomogeneity, and/or pericardial /pleural
effusions with a sensitivity of 0.88 and specificity of 0.92.105
Expert consensus key points
(i) CMR is an important part of non-invasive tumour characteriza-
tion by providing information on size, location, haemodynamic
relevance, relationship to the adjacent structures, infiltration,
as well as tissue properties.
Figure6: Two-year-oldgirlwithhypoplastic left heart syndrome(A) andstatuspost-bilateral cavopulmonaryanastomosis andFontancompletion.3D
SSFP images reconstructedwithanMIPtechnique illustrateapatentDamus–Kaye–Stancel (DKS)anastomosis (***)with theoriginof therightcoronary
artery (B); the segment between the right and left pulmonary artery (**) was reconstructed at time of Fontan completion, as it was subatretic due to
external compression of the dilated neo-aortic root (DKS) and presents now with recurrent narrowing (C and D). AO, aorta; C, extracardiac Fontan
conduit; MPA, main pulmonary artery; LA, left atrium; LV, left ventricle; LSVC, left superior vena cava; RA, right atrium; RV, right ventricle.
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Cardiomyopathies
The two most common forms of paediatric cardiomyopathy are dilated
cardiomyopathy (DCM; annual incidence 0.57 cases per 100 000) and
hypertrophic cardiomyopathy (HCM; 0.47 per 100 000 persons).106
In addition to echocardiography, recognized as first-line imaging
modality in children with cardiomyopathy, CMR provides non-
invasive myocardial tissue characterization. In particular, CMR can
detect the presence and extend of myocardial oedema, scarring
Figure 7: Embryonic rhabdomyosarcoma (**) in the apex of the right ventricle in a 3-month-old boy. SSFP (A), T1-weighted (B), and T2-weighted
images (C ) in an axial plane demonstrate different tissue characteristics in different sequences. Short-axis post-contrast images (D) show contrast
medium enhancement particularly in the superficial tissue layers and less in the core of the tumour. LV, left ventricle; RV, right ventricle.
Figure 8: Appearance of intracavity thrombus on 2D SSFP (A) and LGE images (B).
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and replacement fibrosis with high spatial resolution. In adults,
pattern of fibrosis on LGE images may point towards the aetiology
of the disease, and may influence decision-making and patient man-
agement.107,108
A wide range of abnormalities detectable with CMR have been
related to the DCM phenotype, including coronary artery anomalies,
idiopathic disease (majority of cases), or secondary causes, such as
myocarditis or neuromuscular disorders. CMR is able to exclude
anomalies of the origin and proximal course of the coronary arteries
without the use of radiation and non-invasively.109 In the acute phase
of myocarditis, CMRcan be used to assess global ventricular function,
detect regional wall motion abnormalities (2D SSFP cine imaging),
early myocardial inflammatory changes (T2-weighted imaging), as
well as myocardial cell necrosis/fibrosis (LGE imaging) (Table 2).110
In chronic myocarditis, CMRcan be used for monitoring biventricular
function111 and demonstrate resolution of the inflammatory pro-
cesses as well as late myocardial remodelling.107 The pattern of con-
trast distribution using LGE imaging is typically nodular, patchy, with a
subepicardial and mid-wall myocardial distribution most commonly
seen in the lateral and inferior walls of the left ventricle. In children,
the extension of contrast is usually subepicardial, but may become
transmural (Figure 9).110 The presence of pericardial effusion
provides supportive evidence for myocarditis. CMR parameters sig-
nificantly associated with poor outcomes in adult patients are: trans-
mural myocardial late enhancement, global hypokinesia, LV dilation,
and LV ejection fraction ,30%. In neuromuscular disorders, CMR
provides information about the degree of myocardial fibrosis, inflam-
mation and impairment of myocardial contractility and relaxation. In
patients with Duchenne muscular dystrophy, LGE allows identifica-
tion of subjects at risk for progressive heart failure.112
In HCM, CMR provides accurate quantification of ventricular mass
and function of both ventricles. The distribution of hypertrophy can
be best delineated by acquiring images in several planes, and particu-
larly apical hypertrophy can be detected more accurately than with
echocardiography. The presence of fibrosis on LGE imaging is a
potential risk factor for ventricular arrhythmias in adults113 and is
observed more rarely in children. If HCM is related to an inborn
error of metabolism (8%), such as Fabry’s or Pompe’s diseases,
CMR may be used to serially monitor the effects of enzyme replace-
ment therapy.114
In left ventricular non-compaction, definition of criteria is challen-
ging and controversial. LGE may not be present in children.115 Never-
theless, CMR has increased diagnostic accuracy compared with
echocardiography, given that the anatomy of the cavity and trabecu-
lae can be more clearly visualized.116
Assessment of myocardial iron load using T2
* measurements is an
established tool in the diagnosis of cardiac haemochromatosis in
patients requiring repeated blood transfusions. The optimal timing
for screening young patients by CMR is under debate, and depends
on patient age and transfusion burden. Often, CMR can be postponed
until 8 yearsof age so that anaesthesia is not required.A singlemeasure
of mid-septal T2
* is sufficient and correlates well with the global T2
*.117
CMR imaging of arrhythmogenic right ventricular cardiomyopathy
(ARVC) in children is challenged by the evolving nature of the
disease.118,119 Thus, repeated studies have been recommended. Mor-
phological and regional wall motion abnormalities must be evaluated
by careful analysis of SSFP cine images in different planes and orienta-
tions. CMR-based criteria for ARVC according to the revised Task
Force Criteria include RV akinesia/dyskinesia, but only when combined
with RV dilatation and/or reduced ejection fraction.120 Imaging of fatty
infiltration or LGE appears to be of low yield in children.119
Expert consensus key points
(i) At time of diagnosis and during follow-up of patients with car-
diomyopathies, the strengths of CMR are specific tissue charac-
terization and accurate quantification of ventricular volume and
function.
(ii) In dilatative cardiomyopathy, CMR can aid in determining the
aetiology of the disease.
Figure9: Focalmyocarditis in a4-year-old child whopresentedwith chestpain and elevated cardiacenzymes. LGE images in a horizontal long-axis
view (A) and in short axis (B). Enhancement is found in the mid-wall of the lateral wall (arrows). 2D SSFP cine showed mild hypocontractility of the
lateral wall, correspondingly.
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(iii) In HCM, CMR is used for exact quantification of myocardial
mass, delineation of the distribution of hypertrophy, as well as
for detection and quantification of myocardial fibrosis.
Coronary arteries/perfusion
In children, imaging of the coronary arteries (CA) and evaluation of
myocardial perfusion with first-pass myocardial imaging as well as
the presence of myocardial scars are indicated in suspected congeni-
tal anomalies of the CA, CA fistulas, after surgery for CHD involving
CAtransfer, beforepercutaneous pulmonary valve replacement with
a valve veering stent, and in patients with vasculitis (e.g. Kawasaki,
Takayasu arteritis, or after heart transplantation).33,121,122 Even
though the capability to provide all this combined information
makes CMR a unique modality, cardiac catheterization currently
remains the gold standard for CA imaging in children (Table 1). ECG-
gatedmultidetector row CT is anestablished non-invasivealternative
for CA assessment because it is easy to use, generally available and
exploits fast acquisition times compared with CMR in adults.
However, important limitations in children remain radiation expos-
ure and fast heart rate.123
Magnetic resonance coronary artery (MRCA) imaging of the prox-
imal and mid regions of the major epicardial CA by using 3D SSFP can
be performed in infants and children19,24,124 (Figure 10). As the
patients growth and heart rate decreases, image quality increases.
This technique can be used to detect an anomalous origin and prox-
imal course of the CA.109 Although the ability to asses CA in children
with Kawasaki disease and to evaluate the vessel wall of the CA has
been reported,122 the validity of MRCA for reliable detection of
CA stenoses is unclear.
Assessment of myocardial perfusion with first-pass myocardial
imaging has been validated in the adult population and has been
demonstrated to have a diagnostic performance superior to
SPECT.125,126 The clinical experience in children is limited, but
good sensitivity and specificity have been demonstrated in compari-
son with X-ray coronary angiography.33,34 Performing first-pass
imaging in children (see basic sequences) requires adapting the
acquisition parameters to the higher heart rate and the small dimen-
sions of the heart. Age and body size are still limiting factors, and
infants below the age of 1 year are still considered suboptimal candi-
dates. Nevertheless, myocardial perfusion imaging in older children
may provide crucial additional dynamic information in addition to
static conventional coronary angiography performed by catheteriza-
tion. Moreover, myocardial perfusion imaging can be used for select-
ing patients, who really necessitate invasive coronary angiography.
LGE imaging provides information regarding the viability of myo-
cardial tissue. Areas of late enhancement correlate well with areas
of fibrosis (scars).127 Frequent paediatric indications for LGE
imaging include myocardial infarctions after surgery, CA thrombosis
in Kawasaki disease, follow-up of different CHD, HCM, and myocar-
ditis (Figure 9).34,128,129
Expert consensus key points
(i) In children, CMR can be used for imaging of the proximal segments
of thecoronaryarteriesand forassessmentofmyocardialperfusion.
(ii) High heart rate and small size remain limiting factors in young
children.
Conclusions
CMR has become awidely accepted technique for a large numberof dif-
ferent indications in children with heart disease. Specific cardiac, paedi-
atric as well as imaging expertise is required and should be available in
centresapplyingCMRin thesepatients, asthe imagingapproachrequires
careful tailoring to the specific question and individual patient.
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Figure10: 3D SSFP images of a 7-year-old boy with Kawasaki disease. A curved multiplanar reformat (A) and a volume-rendered 3D reconstruc-
tion (B) demonstrate five aneurysms (asterisks) of the right coronaryartery. AO, aorta; IVC, inferior vena cava; RA, right atrium; RV, right ventricle; A,
anterior; I, inferior; L, left; P, posterior; R, right; S, superior.
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